Our mission is to set a new standard for the understanding of what happens when a novel drug meets the human blood for the first time.
Given the growing number of biologics and immune-targeting drugs, the need to measure and predict the risk of adverse drug reactions in patients is urgent. Animal models fail to address questions related to both safety and effect – resulting in project delays, increased costs and, above all, a non-optimized clinical program with inherent risks for trial participants. With our help, you can obtain preliminary effect data and be more certain that your drug is safe enough to enter the human body. Our goal is to provide truly meaningful insights that help our customers enter clinical trials prepared. Immuneed is a contract research organization specializing in immunology and preclinical drug development. We offer in-house services to address important questions related to the safety and function of biopharmaceuticals. Simply put, we transform potential risks into vital insights.